Skip to main content

IDENTIFICACION DE UN PANEL INTEGRADO DE BIOMARCADORES NO-INVASIVOS PREDICTIVOS DEL DIAGNOSTICO DE COLITIS MICROSCOPICA

PI17/01443

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2017
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Execution centre INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO VALLE DE HEBRON (VHIR)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations

  • Pardo Camacho, Cristina
  • Martínez, Cristina
  • Exposito Fernandez, Elba
  • Albert Bayo, Merce
  • Melón Ardanaz, Elisa
  • Rodiño Janeiro, Bruno Kotska
  • Fortea Guillamon, Marina
  • Rodríguez Urrutia, Amanda
  • Torres Ramirez, Inés de
  • Santos-Briones, Ignacio
  • Azpiroz Vidaur, Fernando
  • Lobo Alvarez, Beatriz
  • Santos Vicente, Fco Javier
  • Gonzalez Castro, Ana Maria
  • Nieto Ruiz, Adoración
  • Guagnozzi, Danila
  • Vicario Perez, Maria
  • Alonso Cotoner, Carmen
  • Pigrau Pastor, Marc
  • Ganda Mall, John-Peter
Intestinal barrier dysfunction; Intestinal glycocalyx; Mucosal nerve fibres, Disfunción de la barrera intestinal; Glicocálix intestinal; Fibras nerviosas de la mucosa, Disfunció de la barrera intestinal; Glicocàlix intestinal; Fibres nervioses de la mucosa, Irritable bowel syndrome (IBS) is a disorder of brain-gut interaction characterised by abdominal pain and changes in bowel habits. In the diarrhoea subtype (IBS-D), altered epithelial barrier and mucosal immune activation are associated with clinical manifestations. We aimed to further evaluate plasma cells and epithelial integrity to gain understanding of IBS-D pathophysiology. One mucosal jejunal biopsy and one stool sample were obtained from healthy controls and IBS-D patients. Gastrointestinal symptoms, stress, and depression scores were recorded. In the jejunal mucosa, RNAseq and gene set enrichment analyses were performed. A morphometric analysis by electron microscopy quantified plasma cell activation and proximity to enteric nerves and glycocalyx thickness. Immunoglobulins concentration was assessed in the stool. IBS-D patients showed differential expression of humoral pathways compared to controls. Activation and proximity of plasma cells to nerves and IgG concentration were also higher in IBS-D. Glycocalyx thickness was lower in IBS-D compared to controls, and this reduction correlated with plasma cell activation, proximity to nerves, and clinical symptoms. These results support humoral activity and loss of epithelial integrity as important contributors to gut dysfunction and clinical manifestations in IBS-D. Additional studies are needed to identify the triggers of these alterations to better define IBS-D pathophysiology., This study was funded in part by Fondo Europeo de Desarrollo Regional (FEDER), Fondo de Investigación Sanitaria and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Subdirección General de Investigación Sanitaria, Ministerio de Economía y Competitividad: CP18/00116 (C.M.), PI19/01643 (B.L.); PI17/01443 (D.G.); PI15/00301 (C.A.-C.), PI17/0190 (J.S.), PI19/01643 & CPII16/00031, (M.V.); CIBEREHD CB06/04/0021 (F.A., C.A.-C., J.S., M.V.); Ministerio de Educación, Dirección General de Investigación: SAF 2016-76648-R (F.A.); Agència de Gestió d’Ajuts Universitaris i de Recerca, de la Generalitat de Catalunya: 2014 SGR 1285 (F.A.); Vall d’Hebron Institut de Recerca, Programa de becas predoctorales Amics de Vall d’Hebron: PRED-VHIR-2016-34 (C.P.-C.), PRED-VHIR-2014-018 (M.F.), the Swedish Research Council dnr 2019-00653 (J.-P.G.M.), and the European Union’s Horizon research and innovation programme 2020, grant no. 848228 (E.E., A.R.-U., B.L., C.A.-C., J.S.).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Integrated Multi-Omic Analysis Identifies Altered Colonic Brush Border Profile as a Key Feature of Microscopic Colitis

  • Fernández-Bañares, Fernando
  • Münch, Andreas
  • Tristan Lopez, Eva
  • Benages, Ana
  • Castillo Cejas, María Dolores
  • Joan, Dot Bach
  • Guagnozzi, Danila
  • González Castro, Ana Maria
  • Zabana, Yamile
  • lobo, beatriz
  • Alonso Cotoner, Carmen
  • Expósito , Elba
  • Landolfi, Stefania
  • Llerena Castro, Ronald
  • Santos, Javier
  • Vicario Perez, Maria
Brush border; Collagenous colitis; Lymphocytic colitis, Vora en raspall; Colitis col·lagenosa; Colitis limfocítica, Borde en cepillo; Colitis colagenosa; Colitis linfocítica, Background Microscopic colitis (MC), comprising lymphocytic colitis (LC) and collagenous colitis (CC), is an inflammatory bowel disease with increasing incidence. MC etiopathogenesis remains unknown; however, altered colonic epithelial integrity may underlie uncontrolled luminal antigen passage, triggering immuno-inflammatory responses. Objective The aim of this study was to further define the involvement of the colonic epithelium in MC. Methods A paired transcriptomic and proteomic analysis followed by epithelial ultrastructural examination was performed on colonic biopsies from LC and CC patients, and from irritable bowel syndrome with a predominance of diarrhoea (IBS-D) and healthy subjects (H) as control groups. The impact of budesonide therapy on the epithelial structure was also evaluated in CC. Results MC patients exhibited decreased expression of inter-microvilli adhesion and actin-bundling proteins, accompanied by increased expression of actin-membrane connection proteins compared to both control groups. Distinct molecular differentiated CC and LC, which translated into differential ultrastructure abnormalities. The colonic microvilli in CC patients were shorter in length and fewer in number, with partial restoration following budesonide treatment, whereas LC showed a reduction solely in microvilli number. A negative correlation was found between daily stool frequency and SPATN1 and ATP8B1 protein levels in CC patients. Conclusions Molecular dysregulation and aberrant ultrastructure of the colonic brush border feature the colonic epithelium in LC and CC. These previously undescribed findings provide new perspectives for further defining MC pathogenesis and identifying biomarkers for diagnosis, prognosis and treatment of this debilitating and prevalent disease., This work was supported by: ‘Gonzalo Miño’ grant (to D.G.) from the Spanish Association of Gastroenterology (AEG): ‘Multicentre study: involvement of the colonic epithelium in the pathophysiology of microscopic colitis’ (2018–2020); Project [PI17/01443 to DG] funded by Instituto de Salud Carlos III and co-funded by the European Union (ERDF/ESF): ‘Identification of an integrated panel of non-invasive predictive biomarkers for the diagnosis of microscopic colitis’ (2018–2021); [ACCES-16 Phase III to M.V.]: ‘Ultrastructural analysis of the colonic epithelium in microscopic colitis’ (CIBEREHD-ISCIII) (2016); Framework collaboration agreement (to D.G., A.M., M.V.) with Linköping Hospital with economic contributions in the field of ‘Microvilli in microscopic colitis’. Project [PI19/01643 to M.V.] funded by Instituto de Salud Carlos III and co-funded by the European Union (ERDF/ESF): ‘Distinctive contribution of the intestinal epithelium to the pathophysiology of chronic diarrhoea in irritable bowel syndrome and microscopic colitis. Integromic profiling for differential diagnosis’ (2020–2023). The founders of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the manuscript.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome

  • Salvo-Romero, Eloísa
  • Martínez, Cristina|||0000-0002-9368-1356
  • Lobo Álvarez, Beatriz|||0000-0003-3391-7125
  • Rodiño-Janeiro, Bruno K.|||0000-0002-0633-6774
  • Pigrau Pastor, Marc|||0000-0001-6801-3017
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • González Castro, Ana Maria|||0000-0003-3955-3318
  • Fortea, Marina|||0000-0001-8885-7495
  • Pardo-Camacho, Cristina
  • Nieto Ruiz, Adoración|||0000-0002-3421-2840
  • Expósito, Elba|||0000-0001-6088-3149
  • Guagnozzi, Danila|||0000-0002-6171-1901
  • Rodríguez-Urrutia, Amanda|||0000-0001-6882-205X
  • de Torres, Inés|||0000-0002-5495-9140
  • Farré, Ricard|||0000-0001-7158-171X
  • Azpiroz Vidaur, Fernando|||0000-0002-7327-960X
  • Alonso Cotoner, Carmen|||0000-0002-3483-2919
  • Santos, Javier|||0000-0002-4798-5033
  • Vicario Perez, Maria|||0000-0001-9622-3185
Corticotropin-releasing factor (CRF) has been identified in intestinal mucosal eosinophils and associated with psychological stress and gut dysfunction. Irritable bowel syndrome (IBS) is commonly characterized by altered intestinal motility, immune activation, and increased gut barrier permeability along with heightened susceptibility to psychosocial stress. Despite intensive research, the role of mucosal eosinophils in stress-associated gut dysfunction remains uncertain. In this study, we evaluated eosinophil activation profile and CRF content in the jejunal mucosa of diarrhea-predominant IBS (IBS-D) and healthy controls (HC) by gene/protein expression and transmission electron microscopy. We also explored the association between intestinal eosinophil CRF and chronic stress, and the potential mechanisms underlying the stress response by assessing eosinophil response to neuropeptides. We found that mucosal eosinophils displayed higher degranulation profile in IBS-D as compared to HC, with increased content of CRF in the cytoplasmic granules, which significantly correlated with IBS clinical severity, life stress background and depression. Eosinophils responded to substance P and carbachol by increasing secretory activity and CRF synthesis and release, without promoting pro-inflammatory activity, a profile similar to that found in mucosal eosinophils from IBS-D. Collectively, our results suggest that intestinal mucosal eosinophils are potential contributors to stress-mediated gut dysfunction through CRF production and release.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome, Jejunal Barrier Alterations Underlying Clinical Manifestations

  • Pardo-Camacho, Cristina
  • Ganda Mall, John-Peter|||0000-0002-2120-7743
  • Martínez, Cristina|||0000-0002-9368-1356
  • Pigrau Pastor, Marc|||0000-0001-6801-3017
  • Expósito, Elba|||0000-0001-6088-3149
  • Albert-Bayo, Mercé|||0000-0002-9726-8083
  • Melón-Ardanaz, Elisa
  • Nieto Ruiz, Adoración|||0000-0002-3421-2840
  • Rodiño-Janeiro, Bruno
  • Fortea, Marina|||0000-0001-8885-7495
  • Guagnozzi, Danila|||0000-0002-6171-1901
  • Rodríguez-Urrutia, Amanda|||0000-0001-6882-205X
  • de Torres, Inés|||0000-0002-5495-9140
  • Santos-Briones, Ignacio
  • Azpiroz Vidaur, Fernando|||0000-0002-7327-960X
  • Lobo Álvarez, Beatriz|||0000-0003-3391-7125
  • Alonso Cotoner, Carmen|||0000-0002-3483-2919
  • Santos, Javier|||0000-0002-4798-5033
  • González Castro, Ana Maria|||0000-0003-3955-3318
  • Vicario Perez, Maria|||0000-0001-9622-3185
Irritable bowel syndrome (IBS) is a disorder of brain-gut interaction characterised by abdominal pain and changes in bowel habits. In the diarrhoea subtype (IBS-D), altered epithelial barrier and mucosal immune activation are associated with clinical manifestations. We aimed to further evaluate plasma cells and epithelial integrity to gain understanding of IBS-D pathophysiology. One mucosal jejunal biopsy and one stool sample were obtained from healthy controls and IBS-D patients. Gastrointestinal symptoms, stress, and depression scores were recorded. In the jejunal mucosa, RNAseq and gene set enrichment analyses were performed. A morphometric analysis by electron microscopy quantified plasma cell activation and proximity to enteric nerves and glycocalyx thickness. Immunoglobulins concentration was assessed in the stool. IBS-D patients showed differential expression of humoral pathways compared to controls. Activation and proximity of plasma cells to nerves and IgG concentration were also higher in IBS-D. Glycocalyx thickness was lower in IBS-D compared to controls, and this reduction correlated with plasma cell activation, proximity to nerves, and clinical symptoms. These results support humoral activity and loss of epithelial integrity as important contributors to gut dysfunction and clinical manifestations in IBS-D. Additional studies are needed to identify the triggers of these alterations to better define IBS-D pathophysiology.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Integrated Multi-Omic Analysis Identifies Altered Colonic Brush Border Profile as a Key Feature of Microscopic Colitis

  • Fernández-Bañares, Fernando
  • Münch, Andreas
  • Tristan Lopez, Eva
  • Benages, Ana
  • Castillo Cejas, María Dolores
  • Joan, Dot Bach
  • Guagnozzi, Danila
  • González Castro, Ana Maria
  • Zabana, Yamile
  • lobo, beatriz
  • Alonso Cotoner, Carmen
  • Expósito , Elba
  • Landolfi, Stefania
  • Llerena Castro, Ronald
  • Santos, Javier
  • Vicario Perez, Maria
Brush border; Collagenous colitis; Lymphocytic colitis, Vora en raspall; Colitis col·lagenosa; Colitis limfocítica, Borde en cepillo; Colitis colagenosa; Colitis linfocítica, Background Microscopic colitis (MC), comprising lymphocytic colitis (LC) and collagenous colitis (CC), is an inflammatory bowel disease with increasing incidence. MC etiopathogenesis remains unknown; however, altered colonic epithelial integrity may underlie uncontrolled luminal antigen passage, triggering immuno-inflammatory responses. Objective The aim of this study was to further define the involvement of the colonic epithelium in MC. Methods A paired transcriptomic and proteomic analysis followed by epithelial ultrastructural examination was performed on colonic biopsies from LC and CC patients, and from irritable bowel syndrome with a predominance of diarrhoea (IBS-D) and healthy subjects (H) as control groups. The impact of budesonide therapy on the epithelial structure was also evaluated in CC. Results MC patients exhibited decreased expression of inter-microvilli adhesion and actin-bundling proteins, accompanied by increased expression of actin-membrane connection proteins compared to both control groups. Distinct molecular differentiated CC and LC, which translated into differential ultrastructure abnormalities. The colonic microvilli in CC patients were shorter in length and fewer in number, with partial restoration following budesonide treatment, whereas LC showed a reduction solely in microvilli number. A negative correlation was found between daily stool frequency and SPATN1 and ATP8B1 protein levels in CC patients. Conclusions Molecular dysregulation and aberrant ultrastructure of the colonic brush border feature the colonic epithelium in LC and CC. These previously undescribed findings provide new perspectives for further defining MC pathogenesis and identifying biomarkers for diagnosis, prognosis and treatment of this debilitating and prevalent disease., This work was supported by: ‘Gonzalo Miño’ grant (to D.G.) from the Spanish Association of Gastroenterology (AEG): ‘Multicentre study: involvement of the colonic epithelium in the pathophysiology of microscopic colitis’ (2018–2020); Project [PI17/01443 to DG] funded by Instituto de Salud Carlos III and co-funded by the European Union (ERDF/ESF): ‘Identification of an integrated panel of non-invasive predictive biomarkers for the diagnosis of microscopic colitis’ (2018–2021); [ACCES-16 Phase III to M.V.]: ‘Ultrastructural analysis of the colonic epithelium in microscopic colitis’ (CIBEREHD-ISCIII) (2016); Framework collaboration agreement (to D.G., A.M., M.V.) with Linköping Hospital with economic contributions in the field of ‘Microvilli in microscopic colitis’. Project [PI19/01643 to M.V.] funded by Instituto de Salud Carlos III and co-funded by the European Union (ERDF/ESF): ‘Distinctive contribution of the intestinal epithelium to the pathophysiology of chronic diarrhoea in irritable bowel syndrome and microscopic colitis. Integromic profiling for differential diagnosis’ (2020–2023). The founders of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the manuscript.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations

  • Pardo Camacho, Cristina
  • Martínez, Cristina
  • Exposito Fernandez, Elba
  • Albert Bayo, Merce
  • Melón Ardanaz, Elisa
  • Rodiño Janeiro, Bruno Kotska
  • Fortea Guillamon, Marina
  • Rodríguez Urrutia, Amanda
  • Torres Ramirez, Inés de
  • Santos-Briones, Ignacio
  • Azpiroz Vidaur, Fernando
  • Lobo Alvarez, Beatriz
  • Santos Vicente, Fco Javier
  • Gonzalez Castro, Ana Maria
  • Nieto Ruiz, Adoración
  • Guagnozzi, Danila
  • Vicario Perez, Maria
  • Alonso Cotoner, Carmen
  • Pigrau Pastor, Marc
  • Ganda Mall, John-Peter
Intestinal barrier dysfunction; Intestinal glycocalyx; Mucosal nerve fibres, Disfunción de la barrera intestinal; Glicocálix intestinal; Fibras nerviosas de la mucosa, Disfunció de la barrera intestinal; Glicocàlix intestinal; Fibres nervioses de la mucosa, Irritable bowel syndrome (IBS) is a disorder of brain-gut interaction characterised by abdominal pain and changes in bowel habits. In the diarrhoea subtype (IBS-D), altered epithelial barrier and mucosal immune activation are associated with clinical manifestations. We aimed to further evaluate plasma cells and epithelial integrity to gain understanding of IBS-D pathophysiology. One mucosal jejunal biopsy and one stool sample were obtained from healthy controls and IBS-D patients. Gastrointestinal symptoms, stress, and depression scores were recorded. In the jejunal mucosa, RNAseq and gene set enrichment analyses were performed. A morphometric analysis by electron microscopy quantified plasma cell activation and proximity to enteric nerves and glycocalyx thickness. Immunoglobulins concentration was assessed in the stool. IBS-D patients showed differential expression of humoral pathways compared to controls. Activation and proximity of plasma cells to nerves and IgG concentration were also higher in IBS-D. Glycocalyx thickness was lower in IBS-D compared to controls, and this reduction correlated with plasma cell activation, proximity to nerves, and clinical symptoms. These results support humoral activity and loss of epithelial integrity as important contributors to gut dysfunction and clinical manifestations in IBS-D. Additional studies are needed to identify the triggers of these alterations to better define IBS-D pathophysiology., This study was funded in part by Fondo Europeo de Desarrollo Regional (FEDER), Fondo de Investigación Sanitaria and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Subdirección General de Investigación Sanitaria, Ministerio de Economía y Competitividad: CP18/00116 (C.M.), PI19/01643 (B.L.); PI17/01443 (D.G.); PI15/00301 (C.A.-C.), PI17/0190 (J.S.), PI19/01643 & CPII16/00031, (M.V.); CIBEREHD CB06/04/0021 (F.A., C.A.-C., J.S., M.V.); Ministerio de Educación, Dirección General de Investigación: SAF 2016-76648-R (F.A.); Agència de Gestió d’Ajuts Universitaris i de Recerca, de la Generalitat de Catalunya: 2014 SGR 1285 (F.A.); Vall d’Hebron Institut de Recerca, Programa de becas predoctorales Amics de Vall d’Hebron: PRED-VHIR-2016-34 (C.P.-C.), PRED-VHIR-2014-018 (M.F.), the Swedish Research Council dnr 2019-00653 (J.-P.G.M.), and the European Union’s Horizon research and innovation programme 2020, grant no. 848228 (E.E., A.R.-U., B.L., C.A.-C., J.S.).